The U.S. drugmaker expects its annual revenue to be in the range of $58.5 billion to $61.5 billion compared with analysts' average estimate of $63.07 billion.
(Reporting by Leroy Leo in Bengaluru; Editing by Arun Koyyur)
Market Closed -
Other stock markets
|
Pre-market 05:42:32 pm | |||
29.49 USD | +0.61% | 29.58 | +0.32% |
04/06 | Pfizer: article on Lyme vaccine in The Lancet | CF |
04/06 | Pfizer Partners with Abu Dhabi to Advance Research on Sickle Cell Disease | MT |
(Reuters) - Pfizer on Wednesday forecast 2024 revenue that was below Wall Street expectations, and increased its target for cost cuts by $500 million.
The U.S. drugmaker expects its annual revenue to be in the range of $58.5 billion to $61.5 billion compared with analysts' average estimate of $63.07 billion.
(Reporting by Leroy Leo in Bengaluru; Editing by Arun Koyyur)
1st Jan change | Capi. | |
---|---|---|
+2.43% | 17TCr | |
+42.83% | 75TCr | |
+34.11% | 61TCr | |
-5.70% | 36TCr | |
+18.06% | 33TCr | |
+4.63% | 29TCr | |
+18.08% | 25TCr | |
+11.04% | 21TCr | |
-2.90% | 21TCr | |
+6.67% | 16TCr |